Celex Oncology Innovations Limited
PrivateLast Round
VC Round
Sep 1, 2026
Total Funding Raised
$323,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Celex Oncology Innovations Limited operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a VC Round in April 2026.
Celex Oncology Innovations Limited is a biotechnology company that develops targeted cancer therapies by harnessing bioelectricity to target voltage-gated sodium channels.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celex Oncology Innovations Limited Comparables
Compare Celex Oncology Innovations Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novita Pharmaceuticals | 80% | |
| Eli Lilly and Company | 67% | |
| LifeBridge Innovations, PBC | 65% |
For institutional investors. Book with your work email.
Celex Oncology Innovations Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 1, 2026 | ||||
| VC Round | Apr 1, 2026 | ||||
| Grant | Jun 5, 2024 | ||||
| Seed | May 19, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Celex Oncology Innovations Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EIT Health | Grant |
| Namier Capital Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
$33M raised in a VC Round.
- Aug 20, 2026
Monthly visitors grew 176% MoM, reaching 3.2K.
For institutional investors. Book with your work email.
Celex Oncology Innovations Limited Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Celex Oncology Innovations Limited's valuation, stock price, and market status.
Is Celex Oncology Innovations Limited a public or private company?
Celex Oncology Innovations Limited is a private company.
What is the current stock price of Celex Oncology Innovations Limited?
Celex Oncology Innovations Limited is a private company, so its shares have no public market price. Caplight tracks Celex Oncology Innovations Limited's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Celex Oncology Innovations Limited worth (valuation)?
Valuation information for Celex Oncology Innovations Limited is not publicly available.
Can I buy Celex Oncology Innovations Limited stock?
Celex Oncology Innovations Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Celex Oncology Innovations Limited's last funding round?
Celex Oncology Innovations Limited's most recent funding round was VC Round on September 1, 2026.
Who are the main investors in Celex Oncology Innovations Limited?
Key investors in Celex Oncology Innovations Limited include EIT Health, Namier Capital Partners.
Will Celex Oncology Innovations Limited IPO soon?
No public IPO plans have been announced for Celex Oncology Innovations Limited.
How can I track Celex Oncology Innovations Limited secondary market activity?
Caplight tracks bids, offers, and trades in Celex Oncology Innovations Limited's shares on secondary markets.